ArticleScientific reports2018

Development of a novel Hsp90 inhibitor NCT-50 as a potential anticancer agent for the treatment of non-small cell lung cancer.

Seung Yeob Hyun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.